Eutilex
OverviewSuggest Edit
Eutilex ((주)유틸렉스) is a biotech company developing anti-tumor T-cell therapy. Additionally, it offers antibody therapeutics based on its proprietary immunotherapy technology.
| Type | Public | |
| Founded | 2015 | |
| Website | eutilex.com |
Eutilex Online and Social Media Presence
Eutilex's Trends
Eutilex Frequently Asked Questions
When was Eutilex founded?
Eutilex was founded in 2015.
Who are Eutilex competitors?
Competitors of Eutilex include Gossamer Bio, Forty Seven and Amal Therapeutics.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies